Oren Hershkovitz

Vorstandsvorsitzender bei ENLIVEX THERAPEUTICS LTD.

Vermögen: 36 968 $ am 30.04.2024

47 Jahre

Health Technology

Consumer Services

Aktive Positionen von Oren Hershkovitz

Unternehmen	Position	Beginn	Ende
ENLIVEX THERAPEUTICS LTD.	Vorstandsvorsitzender	16.11.2019	-
OPKO Biologics Ltd. OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel.	Direktor/Vorstandsmitglied	01.09.2016	-

Ben-Gurion University of the Negev

Doctorate Degree

International

Israel

Operativ

Sektoral

Health Technology	3
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
ENLIVEX THERAPEUTICS LTD.	Health Technology

Private Unternehmen	1
OPKO Biologics Ltd. OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel.	Health Technology

Private Unternehmen

Health Technology